berberine glp 1 compounds improves hyperglycemia via microbiome mediated colonic TGR5-GLP pathway in db/db mice Is Using Berberine for Weight

It remains unclear whether the imbalanced pharmacology or the longer half-life of tirzepatide contributes to its superior efficacy in glucose and weight reduction compared to the more balanced dual agonist, NNC0090-2746

Mechanisms of Cardiorenal Protection of Glucagon-Like Peptide-1 Receptor Agonists

Pre-clinical studies showed that anti-atherogenic effect of GLP-1 is independent of modulation of plasma lipid levels and depends on anti-inflammatory response

Stimulants, midodrine and tesofensine were added as examples of prohibited stimulants, and guanfacine (sometimes prescribed for ADHD) was clarified as permitted

Editor information Editors and Affiliations Rights and permissions Copyright information 2020 Springer Nature Switzerland AG About this chapter Cite this chapter Maselli, D.B., Camilleri, M